Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Se In Sung

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Stem Cells Translational Medicine|August 23, 2018
Mesenchymal Stem Cells for Severe Intraventricular Hemorrhage in Preterm Infants: Phase I Dose-Escalation Clinical TrialSo Yoon Ahn, Yun Sil Chang, Se In Sung, et al.
Pediatrics and Neonatology|January 24, 2021
Mesenchymal stem cell therapy for intractable neonatal disordersSo Yoon Ahn, Won Soon Park, Se In Sung, et al.
Neonatology|December 21, 2022
Neonatal Intensive Care Quality Level-Dependent Variations in the Survival Rate of Infants with a Birth Weight of 500 g or Less in Korea: A Nationwide Cohort StudyMisun Yang, Yun Sil Chang, So Yoon Ahn, et al.
Stem Cells Translational Medicine|June 4, 2026
Five-year follow-up outcomes after phase 1 trial of mesenchymal stromal cells for periventricular hemorrhagic infarction in preterm infantsMisun Yang, So Yoon Ahn, Se In Sung, et al.
Stem Cells Translational Medicine|August 9, 2024
Improving the future of clinical trials and translation of mesenchymal stromal cell therapies for neonatal disordersYun Sil Chang, Misun Yang, So Yoon Ahn, et al.
Journal of Korean Medical Science|July 1, 2026
Two-Year Outcomes of a Randomized Controlled Trial of Nonintervention Versus Oral Ibuprofen for Patent Ductus Arteriosus in Premature InfantsSe In Sung, Misun Yang, So Yoon Ahn, et al.
Journal of Clinical Medicine|March 8, 2020
Changes in Serum Creatinine Levels and Natural Evolution of Acute Kidney Injury with Conservative Management of Hemodynamically Significant Patent Ductus Arteriosus in Extremely Preterm Infants at 23-26 Weeks of GestationEun Seop Seo, Se In Sung, So Yoon Ahn, et al.
Pediatric Research|October 4, 2017
Strategies to enhance paracrine potency of transplanted mesenchymal stem cells in intractable neonatal disordersWon Soon Park, So Yoon Ahn, Se In Sung, et al.
Journal of Korean Medical Science|December 8, 2017
The Youngest Survivor with Gestational Age of 21⁵/₇ WeeksSe In Sung, So Yoon Ahn, Hye Soo Yoo, et al.
Plos One|February 14, 2018
Predicting mortality in extremely low birth weight infants: Comparison between gestational age, birth weight, Apgar score, CRIB II score, initial and lowest serum albumin levelsJae Hyun Park, Yun Sil Chang, So Yoon Ahn, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Stem Cells Translational Medicine|August 23, 2018
Mesenchymal Stem Cells for Severe Intraventricular Hemorrhage in Preterm Infants: Phase I Dose-Escalation Clinical TrialSo Yoon Ahn, Yun Sil Chang, Se In Sung, et al.
Pediatrics and Neonatology|January 24, 2021
Mesenchymal stem cell therapy for intractable neonatal disordersSo Yoon Ahn, Won Soon Park, Se In Sung, et al.
Neonatology|December 21, 2022
Neonatal Intensive Care Quality Level-Dependent Variations in the Survival Rate of Infants with a Birth Weight of 500 g or Less in Korea: A Nationwide Cohort StudyMisun Yang, Yun Sil Chang, So Yoon Ahn, et al.
Stem Cells Translational Medicine|June 4, 2026
Five-year follow-up outcomes after phase 1 trial of mesenchymal stromal cells for periventricular hemorrhagic infarction in preterm infantsMisun Yang, So Yoon Ahn, Se In Sung, et al.
Stem Cells Translational Medicine|August 9, 2024
Improving the future of clinical trials and translation of mesenchymal stromal cell therapies for neonatal disordersYun Sil Chang, Misun Yang, So Yoon Ahn, et al.
Journal of Korean Medical Science|July 1, 2026
Two-Year Outcomes of a Randomized Controlled Trial of Nonintervention Versus Oral Ibuprofen for Patent Ductus Arteriosus in Premature InfantsSe In Sung, Misun Yang, So Yoon Ahn, et al.
Journal of Clinical Medicine|March 8, 2020
Changes in Serum Creatinine Levels and Natural Evolution of Acute Kidney Injury with Conservative Management of Hemodynamically Significant Patent Ductus Arteriosus in Extremely Preterm Infants at 23-26 Weeks of GestationEun Seop Seo, Se In Sung, So Yoon Ahn, et al.
Pediatric Research|October 4, 2017
Strategies to enhance paracrine potency of transplanted mesenchymal stem cells in intractable neonatal disordersWon Soon Park, So Yoon Ahn, Se In Sung, et al.
Journal of Korean Medical Science|December 8, 2017
The Youngest Survivor with Gestational Age of 21⁵/₇ WeeksSe In Sung, So Yoon Ahn, Hye Soo Yoo, et al.
Plos One|February 14, 2018
Predicting mortality in extremely low birth weight infants: Comparison between gestational age, birth weight, Apgar score, CRIB II score, initial and lowest serum albumin levelsJae Hyun Park, Yun Sil Chang, So Yoon Ahn, et al.
Pageof 10